BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31177175)

  • 1. The Significance of Pregnancy-associated Plasma Protein a Serum Concentration in Clear Cell Renal Cell Carcinoma.
    Cechova M; Chocholaty M; Zima T; Babjuk M; Kalousova M
    Anticancer Res; 2019 Jun; 39(6):3249-3253. PubMed ID: 31177175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma.
    Cechova M; Chocholaty M; Babjuk M; Zima T; Havlova K; Koldova M; Schmidt M; Kalousova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Nov; 165(4):375-379. PubMed ID: 33612835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
    Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
    Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
    Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
    Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma.
    Rodriguez-Covarrubias F; Gomez-Alvarado MO; Sotomayor M; Castillejos-Molina R; Mendez-Probst CE; Gabilondo F; Feria-Bernal G
    Urol Int; 2011; 86(1):47-52. PubMed ID: 20814191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Effect of Preoperative Apolipoprotein B Level in Surgical Patients with Clear Cell Renal Cell Carcinoma.
    Wang K; Wu T; Chen Y; Song G; Chen Z
    Oncol Res Treat; 2020; 43(7-8):340-345. PubMed ID: 32554963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.
    Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E
    Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
    Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
    Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma.
    Fujita N; Okegawa T; Terado Y; Tambo M; Higashihara E; Nutahara K
    BMC Res Notes; 2014 Jun; 7():369. PubMed ID: 24938498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of
    Zhang Y; Zhu X; Qiao X; Sun L; Xia T; Liu C
    Int J Med Sci; 2021; 18(1):239-244. PubMed ID: 33390792
    [No Abstract]   [Full Text] [Related]  

  • 18. Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Ren W; Xue B; Chen M; Liu L; Zu X
    Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
    Väänänen T; Kallio J; Vuolteenaho K; Ojala A; Luukkaala T; Hämäläinen M; Tammela T; Kellokumpu-Lehtinen PL; Moilanen E
    Scand J Urol; 2017 Oct; 51(5):367-372. PubMed ID: 28644702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma.
    Haddad AQ; Luo JH; Krabbe LM; Darwish O; Gayed B; Youssef R; Kapur P; Rakheja D; Lotan Y; Sagalowsky A; Margulis V
    BJU Int; 2017 May; 119(5):741-747. PubMed ID: 28075543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.